Journal of Clinical Endocrinology & Metabolism, Vol 74, 981-988, Copyright © 1992 by Endocrine Society

ARTICLES

Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function

GE Hofmann, MR Drews, RT Scott Jr, D Navot, D Heller and L Deligdisch
Department of Obstetrics and Gynecology, Mount Sinai Medical Center, New York, New York 10029.

Epidermal growth factor (EGF) and its receptor (EGF-R) were immunohistochemically localized in trophoblast during human implantation from intrauterine and ectopic pregnancies. EGF immunostaining was absent to light in the cytotrophoblast (CT), light to moderate in intermediate trophoblast (IT), and intense in the syncytiotrophoblast (ST). In ST, EGF immunostaining was found mostly in the cytoplasm; however, staining of the plasma membrane was also noted. Immunostaining for the EGF-R was absent to light in the CT and moderate to intense in the IT. Immunostaining for the EGF-R was intense in the ST, with moderate staining in the cytoplasm and intense staining in the plasma membrane. Staining was most intense on the microvilli of the ST. Additionally, EGF-R immunostaining could be demonstrated on nuclear membranes. The increase in the intensity of the immunostaining for both EGF and EGF-R noted in CT, IT, and ST suggests a differentiated expression of this receptor-ligand system in human trophoblast and provides evidence for an autocrine/paracrine role for EGF in trophoblast function. The presence of this receptor-ligand system during early human implantation strongly supports a role for EGF and the EGF-R in embryo-uterine signalling and the implantation process.

This article has been cited by other articles:

				R. G. Humphrey, C. Sonnenberg-Hirche, S. D. Smith, C. Hu, A. Barton, Y. Sadovsky, and D. M. Nelson Epidermal Growth Factor Abrogates Hypoxia-Induced Apoptosis in Cultured Human Trophoblasts through Phosphorylation of BAD Serine 112 Endocrinology, May 1, 2008; 149(5): 2131 - 2137. [Abstract] [Full Text] [PDF]

				C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF]

				M. Yang, Z. M. Lei, and Ch. V. Rao The Central Role of Human Chorionic Gonadotropin in the Formation of Human Placental Syncytium Endocrinology, March 1, 2003; 144(3): 1108 - 1120. [Abstract] [Full Text] [PDF]

				S Stone, M A Khamashta, and L Poston Placentation, antiphospholipid syndrome and pregnancy outcome Lupus, February 1, 2001; 10(2): 67 - 74. [Abstract] [PDF]

				Y. Kamei, O. Tsutsumi, A. Yamakawa, Y. Oka, Y. Taketani, and J. Imaki Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression Endocrinology, September 1, 1999; 140(9): 4236 - 4243. [Abstract] [Full Text]

				M. R. Bush, J. M. Mele, G. M. Couchman, and D. K. Walmer Evidence of Juxtacrine Signaling for Transforming Growth Factor {alpha} inHuman Endometrium Biol Reprod, December 1, 1998; 59(6): 1522 - 1529. [Abstract] [Full Text]

				A. Koman, S. Cazaubon, P.-O. Couraud, A. Ullrich, and A. D. Strosberg Molecular Characterization and in Vitro Biological Activity of Placentin, a New Member of the Insulin Gene Family J. Biol. Chem., August 23, 1996; 271(34): 20238 - 20241. [Abstract] [Full Text] [PDF]

				M. J. Slowey, H. G. Verhage, and A. T. Fazleabas Epidermal Growth Factor, Transforming Growth Factor-{alpha}, and Epidermal Growth Factor Receptor Localization in the Baboon (Papio anubis) Uterus During the Menstrual Cycle and Early Pregnancy Reproductive Sciences, October 1, 1994; 1(4): 277 - 284. [Abstract] [PDF]